Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
Status:
Completed
Trial end date:
2009-05-20
Target enrollment:
Participant gender:
Summary
To evaluate the effect of rufinamide on total partial seizure frequency in adolescent and
adult participants (12 to 80 years, inclusive) with refractory partial onset seizures
maintained on a maximum of 3 stable antiepileptic drugs (AEDs).